{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:59:45Z","timestamp":1787950785571,"version":"build-2784847793"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To provide the most recent evidence on the overlap myositis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Several new evidences on the overlap myositides have recently emerged. Regarding the classical myositis associated antibodies, several contributions focused on a better definition of the clinical associations and the disease course associated with these autoantibodies. Moreover, in the last years, new autoantibodies in idiopathic inflammatory myositis or other connective tissue diseases have been identified [namely anti-RuvBL1\/2, poly-U-binding factor 60\u200akDa protein (PUF-60) and cytosolic 5\u2032-nucleotidase 1A (NT5C1A)], and an increasing number of publications allow now to consider them as new myositis-associated antibodies with probably their own peculiar clinical profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Overlap myositis is probably the largest subgroup within the idiopathic inflammatory myositis, with a prevalence that can reach 50% of all adult patients. The serological spectrum of overlap myositis has recently been enriched by the discovery of new autoantibodies. The spread of multiparametric methods has facilitated the identification of the autoantibody marker of overlap myositis and the better definition of the clinical profiles associated with them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000536","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T18:09:07Z","timestamp":1533146947000},"page":"637-643","source":"Crossref","is-referenced-by-count":30,"title":["The clinico-serological spectrum of overlap myositis"],"prefix":"10.1097","volume":"30","author":[{"given":"Micaela","family":"Fredi","sequence":"first","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia"},{"name":"Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, ASST-Spedali Civili of Brescia"},{"name":"Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","article-title":"Overlap connective tissue disease syndromes","volume":"12","author":"Iaccarino","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","article-title":"Advances in serological diagnostics of inflammatory myopathies","volume":"29","author":"Benveniste","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","article-title":"Myositis autoantibodies and clinical phenotypes","volume":"5","author":"Ghirardello","year":"2014","journal-title":"Auto Immun Highlights"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.40063","article-title":"Editorial: a new classification of adult autoimmune myositis","volume":"69","author":"Sen\u00e9cal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2017.01.008","article-title":"Clinical follow-up predictors of disease pattern change in anti-Jo1 positive antisynthetase syndrome: results from a multicenter, international and retrospective study","volume":"16","author":"Bartoloni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R7-20230901","first-page":"2271","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"e4713","DOI":"10.1097\/MD.0000000000004713","article-title":"Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations","volume":"95","author":"Hoa","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R9-20230901","first-page":"2","article-title":"A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies","volume":"31","author":"Cavazzana","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/1756-185X.13060","article-title":"Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais","volume":"20","author":"Foocharoen","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","article-title":"Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease","volume":"91","author":"Rigolet","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2169\/internalmedicine.9363-17","article-title":"Dropped head syndrome and the presence of rimmed vacuoles in a muscle biopsy in scleroderma\u2013polymyositis overlap syndrome associated with anti-Ku antibody","volume":"57","author":"Yoshida","year":"2018","journal-title":"Intern Med"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns (ICAP) 2014\u20132015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3899\/jrheum.101248","article-title":"Clinical and serological hallmarks of systemic sclerosis overlap syndromes","volume":"38","author":"Pakozdi","year":"2011","journal-title":"J Rheumatol"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0573-x","article-title":"Anti-PM\/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma","volume":"17","author":"Muro","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","article-title":"Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis","volume":"33","author":"Aguila","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4314\/ahs.v17i2.38","article-title":"Recovery from severe dysphagia in systemic sclerosis \u2013 myositis overlap: a case report","volume":"17","author":"Chinniah","year":"2017","journal-title":"Afr Health Sci"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1111\/bjd.15371","article-title":"Image gallery: palmoplantar hyperkeratosis in dermatomyositis with anti-PM\/Scl antibodies","volume":"176","author":"Taki","year":"2017","journal-title":"Br J Dermatol"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5414\/NP301077","article-title":"Idiopathic inflammatory myopathies overlapping with systemic diseases","volume":"37","author":"Lepreux","year":"2018","journal-title":"Clin Neuropathol"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/BOR.0000000000000336","article-title":"Myopathy in scleroderma and in other connective tissue diseases","volume":"28","author":"Paik","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2016.12.014","article-title":"Interstitial lung disease and myositis-specific and associated autoantibodies: clinical manifestations, survival and the performance of the new ATS\/ERS criteria for interstitial pneumonia with autoimmune features (IPAF)","volume":"123","author":"Mej\u00eda","year":"2017","journal-title":"Respir Med"},{"key":"R24-20230901","first-page":"303","article-title":"Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options","volume":"35","author":"Fredi","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3899\/jrheum.151445","article-title":"Four cases of anti-PM\/Scl antibody-positive juvenile overlap syndrome with features of myositis and systemic sclerosis","volume":"43","author":"Fotis","year":"2016","journal-title":"J Rheumatol"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/sji.12510","article-title":"The clinical relevance of antifibrillarin (anti-U3-RNP) autoantibodies in systemic sclerosis","volume":"85","author":"Tall","year":"2017","journal-title":"Scand J Immunol"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","article-title":"Presence of antieukaryotic initiation factor-2B, anti-RuvBL1\/2 and antisynthetase antibodies in patients with antinuclear antibody negative systemic sclerosis","volume":"57","author":"Pauling","year":"2018","journal-title":"Rheumatol"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08916930400022715","article-title":"Anti-Sm and anti-RNP antibodies","volume":"38","author":"Migliorini","year":"2005","journal-title":"Autoimmunity"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13075-017-1494-7","article-title":"Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study","volume":"19","author":"Reiseter","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.rdc.2005.04.003","article-title":"Muscle involvement in mixed connective tissue disease","volume":"31","author":"Hall","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/1756-185X.12592","article-title":"SLE myopathy: a clinicopathological study","volume":"18","author":"Jakati","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.12659\/MSM.902016","article-title":"Associated variables of myositis in systemic lupus erythematosus: a cross-sectional study","volume":"23","author":"Liang","year":"2017","journal-title":"Med Sci Monit"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.berh.2016.02.005","article-title":"Inflammatory myopathies and overlap syndromes: update on histological and serological profile","volume":"29","author":"Colafrancesco","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874312901610010122","article-title":"Anti-MDA5 antibody dermatomyositis overlap with systemic lupus erythematosus: a case report and review of the literature","volume":"10","author":"Milam","year":"2016","journal-title":"Open Rheumatol J"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1503\/cmaj.160783","article-title":"Sex differential association of dermatomyositis with Sj\u00f6gren syndrome","volume":"189","author":"Tseng","year":"2017","journal-title":"CMAJ"},{"key":"R38-20230901","first-page":"457","article-title":"Myositis in primary Sj\u00f6gren's syndrome: data from a multicentre cohort","volume":"33","author":"Colafrancesco","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R39-20230901","first-page":"781","article-title":"Rheumatoid myositis, myth or reality? A clinical, Imaging and histological study","volume":"55","author":"Ancu\u0163a","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the antisynthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J Rheumatol"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J Rheumatol"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"448","DOI":"10.12659\/AJCR.903540","article-title":"A rare case of necrotizing myopathy and fibrinous and organizing pneumonia with anti-EJ antisynthetase syndrome and SSA antibodies","volume":"18","author":"Kashif","year":"2017","journal-title":"Am J Case Rep"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","article-title":"PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sj\u00f6gren's syndrome","volume":"75","author":"Fiorentino","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s10067-018-4031-4","article-title":"The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2017.07.002","article-title":"Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts","volume":"472","author":"Muro","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2017-212436","article-title":"Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis","volume":"77","author":"Yeker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R51-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","article-title":"Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera","volume":"433","author":"Cavazzana","year":"2016","journal-title":"J Immunol Methods"},{"key":"R52-20230901","first-page":"176","article-title":"Autoantibody testing in patients with myositis: clinical accuracy of a multiparametric line immunoassay","volume":"35","author":"Ghirardello","year":"2017","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:17:57Z","timestamp":1693516677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000536","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}